As trade tensions between the U.S. and China reignite, impacting global markets, Asian tech stocks continue to capture attention with their potential for high growth amid evolving economic landscapes. In such an environment, identifying promising tech stocks involves looking at companies that demonstrate resilience through innovation and adaptability to shifting market dynamics.
Name
Revenue Growth
Earnings Growth
Growth Rating
Giant Network Group
31.77%
34.18%
★★★★★★
Fositek
34.27%
44.80%
★★★★★★
Zhongji Innolight
28.78%
30.84%
★★★★★★
ASROCK Incorporation
28.31%
29.76%
★★★★★★
Shengyi Electronics
23.36%
30.38%
★★★★★★
Gold Circuit Electronics
26.64%
35.16%
★★★★★★
Foxconn Industrial Internet
28.21%
27.66%
★★★★★★
eWeLLLtd
25.02%
24.93%
★★★★★★
ALTEOGEN
56.27%
65.14%
★★★★★★
CARsgen Therapeutics Holdings
100.40%
118.16%
★★★★★★
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Celltrion, Inc. is a biopharmaceutical company focused on developing, producing, and selling therapeutic proteins for oncology treatments, with a market cap of ₩37.65 trillion.
Operations: The company primarily generates revenue from its biopharmaceutical segment, which accounts for ₩6.66 trillion, while its chemical drugs segment contributes ₩517 billion.
Celltrion’s recent FDA approval of EYDENZELT®, a biosimilar for ophthalmic conditions, marks a significant stride in its biologics segment, potentially boosting its market presence in the U.S. This approval aligns with their robust R&D focus, which is evident from their consistent investment in innovation; R&D expenses have notably increased by 12% year-over-year. Additionally, Celltrion has demonstrated strong financial health with a 15.3% annual revenue growth and an impressive 28.1% surge in earnings, outpacing the broader Korean market’s growth rates. These developments not only enhance Celltrion’s competitive edge but also underscore its commitment to expanding therapeutic options globally, positioning it well for sustained growth amidst dynamic industry challenges.
KOSE:A068270 Earnings and Revenue Growth as at Oct 2025
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Yidu Tech Inc. is an investment holding company that offers healthcare solutions leveraging big data and artificial intelligence technologies across the People’s Republic of China, Brunei, Singapore, and other international markets, with a market cap of approximately HK$6.36 billion.
Story Continues
Operations: Yidu Tech generates revenue through three primary segments: Life Sciences Solutions (CN¥247.11 million), Big Data Platform and Solutions (CN¥345.89 million), and Health Management Platform and Solutions (CN¥121.98 million). The company leverages its expertise in big data and AI to provide these healthcare solutions across multiple regions, focusing on enhancing efficiency and outcomes in the healthcare sector.
Yidu Tech’s strategic share repurchases, including the recent buyback of 3.09 million shares for HKD 10.84 million, underscore its commitment to enhancing shareholder value amidst challenging market conditions. Despite currently being unprofitable, Yidu Tech is anticipated to pivot into profitability within three years, with earnings expected to surge by approximately 99.8% annually. This growth trajectory is supported by a robust annual revenue increase of 15.1%, outstripping the Hong Kong market’s average of 8.7%. These financial maneuvers and forecasts reflect Yidu Tech’s potential resilience and adaptability in the fast-evolving tech landscape in Asia, positioning it as a noteworthy contender in high-growth sectors despite its present challenges.
SEHK:2158 Revenue and Expenses Breakdown as at Oct 2025
Simply Wall St Growth Rating: ★★★★★☆
Overview: Rakus Co., Ltd., along with its subsidiaries, offers cloud services in Japan and has a market capitalization of approximately ¥448.92 billion.
Operations: Rakus Co., Ltd. specializes in providing cloud services across Japan, focusing on innovative solutions for businesses. The company leverages its expertise to drive revenue through subscription-based models, catering to a diverse clientele seeking efficient digital transformation tools.
Rakus, amid a dynamic market, has demonstrated impressive agility with its recent strategic alliance aimed at enhancing sales and customer satisfaction. This move aligns with their robust earnings forecast, expected to grow by 23.4% annually, outpacing the Japanese market’s average growth. Additionally, Rakus has adjusted its dividend guidance following a stock split, reflecting adaptability in shareholder engagement strategies. With consistent revenue growth of 15.8% annually—surpassing Japan’s 4.4% average—Rakus is solidifying its position in the competitive back-office SaaS sector by leveraging strong partnerships and innovative service enhancements to boost client productivity and competitiveness.
TSE:3923 Revenue and Expenses Breakdown as at Oct 2025
Click here to access our complete index of 187 Asian High Growth Tech and AI Stocks.
Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St’s portfolio, where intuitive tools await to help optimize your investment outcomes.
Discover a world of investment opportunities with Simply Wall St’s free app and access unparalleled stock analysis across all markets.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KOSE:A068270 SEHK:2158 and TSE:3923.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com